CPRX Financial Facts

Loss before income taxes: -3.2M
Interest income: 15.74K
See Full Income Statement

Cash and cash equivalents: 14.8M
Accrued expenses and other liabilities: 1.13M
See Full Balance Sheet

Catalyst Pharmaceutical Partners Inc. (CPRX) Earnings

  |   Expand Research on CPRX
Next EPS Date 11/14/14 *Est. EPS Growth Rate +16.7% *Last Qtr.
Average EPS % Beat Rate +28.0% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +14.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/14/14 Q214 -$0.05-$0.07 +$0.02N/AN/A N/A Details
5/16/14 Q114 -$0.07-$0.06 -$0.01N/AN/A N/A Details
3/19/14 Q413 $0.00-$0.07 +$0.07N/AN/A N/A Details
11/14/13 Q313 -$0.07-$0.07 $0.00N/AN/A N/A Details
8/15/13 Q213 -$0.06-$0.07 +$0.01N/AN/A N/A Details
5/16/13 Q113 $0.00-$0.08 +$0.08N/AN/A N/A Details
4/2/13 Q412 $0.00-$0.09 +$0.09N/AN/A N/A Details
11/15/12 Q312 -$0.08N/A N/A N/AN/A N/A Details